Structural aspects of N-hydroxy-N′-aminoguanidine derivatives as inhibitors of L1210 cell growth and ribonucleotide reductase activity
- 1 January 1993
- journal article
- Published by Elsevier in Advances in Enzyme Regulation
- Vol. 33, 129-140
- https://doi.org/10.1016/0065-2571(93)90013-4
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Inhibition of ribonucleotide reductase and growth of human colon carcinoma HT-29 cells and mouse leukemia L1210 cells by N-hydroxy-N′-aminoguanidine derivativesBiochemical Pharmacology, 1990
- Molecular cloning of the cDNA for a mutant mouse ribonucleotide reductase M1 that produces a dominant mutator phenotype in mammalian cells.Molecular and Cellular Biology, 1988
- Properties of N-hydroxy-N′-aminoguanidine derivatives as inhibitors of mammalian ribonucleotide reductaseBiochemical Pharmacology, 1988
- Isolation and characterization of expressible cDNA clones encoding the M1 and M2 subunits of mouse ribonucleotide reductase.Molecular and Cellular Biology, 1986
- Inhibition of ribonucleotide reductase and L1210 cell growth by N-hydroxy-N′-aminoguanidine derivativesBiochemical Pharmacology, 1985
- Studies of N-hydroxy-N'-aminoguanidine derivatives by nitrogen-15 nuclear magnetic resonance spectroscopy and as ribonucleotide reductase inhibitorsJournal of Medicinal Chemistry, 1983
- Allosteric regulation of calf thymus ribonucleoside diphosphate reductaseBiochemistry, 1979
- Components and control of ribonucleotide reductase system of the ratAdvances in Enzyme Regulation, 1977
- Ribonucleotide Reductase of Rabbit Bone MarrowPublished by Elsevier ,1972
- A rapid assay for CDP reductase activity in mammalian cell extractsAnalytical Biochemistry, 1970